Brain parenchymal and microvascular amyloid in Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Brain parenchymal and microvascular amyloid in Alzheimer's disease.

Brain parenchymal and microvascular amyloid in Alzheimer's disease.

http://www.wikidata.org/entity/Q41061846

about

Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease Effect of anti-inflammatory agents on transforming growth factor beta over-expressing mouse brains: a model revised Lymphatic Clearance of the Brain: Perivascular, Paravascular and Significance for Neurodegenerative Diseases Genetic variation at CR1 increases risk of cerebral amyloid angiopathy.Exogenous A beta1-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice.A beta-peptides enhance vasoconstriction in cerebral circulation.PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer's disease.Neuropathologic substrates of ischemic vascular dementia.Transgenic mice overexpressing APP and transforming growth factor-beta1 feature cognitive and vascular hallmarks of Alzheimer's disease Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease.Tissue microarrays in the study of non-neoplastic disease of the nervous system.Advances in our Understanding of the Pathophysiology, Detection and Management of Cerebral Amyloid Angiopathy.Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls Aquaporin expression in the brains of patients with or without cerebral amyloid angiopathy Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation Cerebral amyloid angiopathy: pathogenesis and effects on the ageing and Alzheimer brain.Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimer's disease Retinal blood flow in mild cognitive impairment and Alzheimer's disease.Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease.Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy Hereditary and sporadic forms of abeta-cerebrovascular amyloidosis and relevant transgenic mouse models Population-based analysis of pathological correlates of dementia in the oldest old.Developmental aspects of the intracerebral microvasculature and perivascular spaces: insights into brain response to late-life diseases.The pathophysiology and clinical presentation of cerebral amyloid angiopathy.Biomarkers in Alzheimer's disease: a review.The Cerebrovascular Basement Membrane: Role in the Clearance of β-amyloid and Cerebral Amyloid Angiopathy.Cerebral amyloid angiopathy related hemorrhage after stroke thrombolysis: case report and literature review.Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease Structural dynamics of the ΔE22 (Osaka) familial Alzheimer's disease-linked amyloid β-protein.Inflammation complicates an 'age-related' cerebral microangiopathy.Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein.Immunohistochemical characterization of novel monoclonal antibodies against the N-terminus of amyloid β-peptide.The incidence of cerebral amyloid angiopathy in surgically treated intracranial hemorrhage in the Chinese population.Histological and immunohistochemical characteristics of cerebral amyloid angiopathy in elderly dogs.Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study.Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline.Can the retina be used to diagnose and plot the progression of Alzheimer's disease?Impaired retinal microcirculation in patients with Alzheimer's disease.

P2860

Q24682442-0B7EFBDC-74A6-4128-9A16-A87BC2F5055A Q24796292-998E4EFB-9F77-4E6F-9AC6-5F924EBF2E74 Q26753215-E628F711-96E5-4FE2-9B71-848DD3BB70C7 Q30422717-DA20F48F-D996-4F36-9CB6-D7D52FD63737 Q30640089-1C5D7C8A-036D-4472-9308-5401D733E32E Q31030422-44BA6900-F83B-4569-AD57-4A155518FB5F Q33936595-C4DDEACF-FC6F-494A-84F2-9CCAE655775E Q34088144-A0842C81-79AF-49C8-AC62-B5BAC5E96F18 Q34358146-99C4B6C1-F546-4DC1-8B89-1CA4EBF42F22 Q34601458-AA07C8F6-E481-4428-A8F5-46487F9CFB21 Q34769695-D5F91364-8EE3-4B64-B30B-C91DEB2CA0BE Q34994148-7464EAC6-15AD-426D-8CAC-661F351EB927 Q35085065-EE9DE7E3-0413-491B-953D-5B2F16198277 Q35162332-B5F2CFB1-C693-474C-9D86-091F0C945A68 Q35214038-ABE46D7D-00BF-4D2A-AC06-44349CFBDA94 Q35540373-63AC25C5-8FD9-4408-BD53-AB51E190F7AD Q35793406-13AD9F12-C8D2-4460-A28F-BE87CE64CEB6 Q35866579-FDE06866-7B5A-4819-A093-6A58C923BF4C Q36033756-E23C0AD6-05E8-4CB9-83B3-448898B107FE Q36163917-680C0220-0BFF-48C9-9E43-560CA8909C41 Q36229619-82C22D8B-1CC5-4E0A-9EE0-3D0290C2FE52 Q36971369-F7431670-C816-42C8-9143-6B9EF833D55D Q37188278-D52B0C1F-889C-4779-BFCF-DA00B716BAC0 Q37681993-8E2A488F-DD60-4E49-8422-9D132FB9F11A Q37956052-6EC8F6EC-CE28-4515-BE68-0C29EF35E1A3 Q38008170-AD2C66A4-8027-4355-B061-4FB8BF917CB1 Q38027541-A30BD0A8-FDA0-4D10-B412-007E64321191 Q38256961-240B61A9-5181-4076-8BBB-414C4040E38B Q38265871-CEE80A2A-F2AA-4BE8-A033-8F8F15758D1B Q42002890-5CC325C9-736F-431E-AAA1-EDA5E923CE75 Q42067591-A5374AB7-2673-4C10-905C-E3E7E69EAB89 Q42767701-3AC4E47B-4CC3-4445-BEF8-1420F4CE3194 Q44027019-F39D99FD-9DCF-476F-BD7C-16F870A6079D Q44640299-64A6F355-4ED2-4087-9DBA-0380DDCFA5E8 Q45898363-CAB0D5D7-E4F4-4D6A-BD18-11D4764DBD93 Q46519504-7E48C124-3689-4D6E-BA67-E32457F94B28 Q46645719-9666AAA2-071F-45D8-B987-05EFCC42FA67 Q47300836-E2D2916E-86B8-4229-923E-F27A0323C494 Q47315641-F3B162AA-2AC0-4824-8364-5935BAD0A0A4 Q47549495-298890B5-8B85-442E-A860-73B93894A4F6

P2860

Brain parenchymal and microvascular amyloid in Alzheimer's disease.

http://www.wikidata.org/entity/Q41061846

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年学术文章

@wuu

1996年学术文章

@zh-cn

1996年学术文章

@zh-hans

1996年学术文章

@zh-my

1996年学术文章

@zh-sg

1996年學術文章

@yue

1996年學術文章

@zh

1996年學術文章

@zh-hant

name

Brain parenchymal and microvascular amyloid in Alzheimer's disease.

@en

type

label

Brain parenchymal and microvascular amyloid in Alzheimer's disease.

@en

prefLabel

Brain parenchymal and microvascular amyloid in Alzheimer's disease.

@en

P1433

Q41061846-F68F28EC-5ACD-421A-B06E-599177176F8D

P1476

Q41061846-09B1E639-23B2-44C5-9D30-AB89B2D6C71B

P2093

Q41061846-2A866D99-2CFE-40F9-897D-019F931EF2DA

Q41061846-73D0CCFC-9A79-4122-A2EE-B85D77F152FE

Q41061846-9140F816-AF53-4D78-B883-1546E53CC327

P2860

Q41061846-02218AF9-DB8B-4FAA-AE93-C1A8CC6FC3BA

Q41061846-02BBDCAE-8FDD-4947-BD3A-533E86C316E4

Q41061846-05891248-05BE-464E-BCE2-DD30A97F0624

Q41061846-06A7BA6F-1D3E-4E77-AFF2-690518BA6DBF

Q41061846-0936B6E3-1C87-4BCB-B74B-A16ED7850D8C

Q41061846-0B23E872-DDAB-4B41-B237-FAF029E86587

Q41061846-0C2C73FF-8145-4259-A360-8C2C3C009BB5

Q41061846-0D7A013B-E35D-4BEB-AED5-19FABE1026EE

Q41061846-0DBEE8E0-C1CD-4C3F-BFFB-B4B4FA9A15CA

Q41061846-0DF50ECF-3ACA-4CDB-9D8C-549E9C8F153F

P304

Q41061846-79809D7D-EB7E-42F5-AA11-C7D01591A847

P31

Q41061846-092E5229-0B3B-400F-AFC1-5883C7888D23

P356

Q41061846-456EA359-605E-4649-AA38-E4BDCD138929

P433

Q41061846-6EA12958-0824-428E-BC66-450B7C13AD37

P478

Q41061846-B5452305-DE5B-43E4-B3A1-61DE575C330B

P577

Q41061846-FD921F16-1F0D-493A-9589-C7BDA345D8D1

P698

Q41061846-F4644CB3-9B9E-4FBB-BC16-713E8B1A0B82

P921

Q41061846-8C71FAC2-B1CD-4184-99CE-48FAE25D293E

P356

J.1750-3639.1996.TB00799.X

P1433

Brain Pathology

P1476

Brain parenchymal and microvascular amyloid in Alzheimer's disease.

@en

P2093

Secor DL

http://www.w3.org/2001/XMLSchema#string

Vinters HV

http://www.w3.org/2001/XMLSchema#string

Wang ZZ

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

Amyloid plaque core protein in Alzheimer disease and Down syndrome

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Neuropathological stageing of Alzheimer-related changes

Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy: report of two cases and review of the literature.

Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex.

Differences between vascular and plaque core amyloid in Alzheimer's disease.

P304

179-195

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1750-3639.1996.TB00799.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

1996-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8737932

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease